BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 24172570)

  • 1. Recurrence of uveal malignant melanoma: a case report.
    Thapa M; Shrestha GB; Sharma AK; Karki S; Khanal S
    Nepal J Ophthalmol; 2013; 5(2):275-8. PubMed ID: 24172570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and treatment of uveal melanoma.
    Shields JA; Shields CL; De Potter P; Singh AD
    Semin Oncol; 1996 Dec; 23(6):763-7. PubMed ID: 8970600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary Enucleations for Uveal Melanoma: A 7-Year Retrospective Analysis.
    Fabian ID; Tomkins-Netzer O; Stoker I; Arora AK; Sagoo MS; Cohen VM
    Am J Ophthalmol; 2015 Dec; 160(6):1104-1110.e1. PubMed ID: 26344583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The pathological basis of the argument in the treatment of melanoma of the uveal tract].
    Li YP
    Zhonghua Yan Ke Za Zhi; 2012 Nov; 48(11):971-5. PubMed ID: 23302268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No differences in outcome between radical surgical treatment (enucleation) and stereotactic radiosurgery in patients with posterior uveal melanoma.
    Furdova A; Slezak P; Chorvath M; Waczulikova I; Sramka M; Kralik G
    Neoplasma; 2010; 57(4):377-81. PubMed ID: 20429631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment considerations for primary uveal melanoma with choroidal metastasis to the fellow eye.
    Bourla DH; Young TA
    Semin Ophthalmol; 2007; 22(3):175-7. PubMed ID: 17763240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ocular retention in patients with uveal melanoma managed by a multimodality approach].
    García-Alvarez C; Muiños Y; Saornil MA; Almaraz A; López-Lara F; Frutos JM; Muñoz MF
    Arch Soc Esp Oftalmol; 2009 Mar; 84(3):145-9. PubMed ID: 19340720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NCCN Guidelines Insights: Uveal Melanoma, Version 1.2019.
    Rao PK; Barker C; Coit DG; Joseph RW; Materin M; Rengan R; Sosman J; Thompson JA; Albertini MR; Boland G; Carson Iii WE; Contreras C; Daniels GA; DiMaio D; Durham A; Fields RC; Fleming MD; Galan A; Gastman B; Grossman K; Guild V; Johnson D; Karakousis G; Lange JR; ; Margolin K; Nath S; Olszanski AJ; Ott PA; Ross MI; Salama AK; Skitzki J; Swetter SM; Wuthrick E; McMillian NR; Engh A
    J Natl Compr Canc Netw; 2020 Feb; 18(2):120-131. PubMed ID: 32023525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Trends and developments in the management of malignant uveal melanoma].
    Lund OE
    Klin Oczna; 1988; 90(4-5):159-64. PubMed ID: 3071651
    [No Abstract]   [Full Text] [Related]  

  • 10. Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation.
    Krohn J; Monge OR; Skorpen TN; Mørk SJ; Dahl O
    Eye (Lond); 2008 Nov; 22(11):1398-403. PubMed ID: 17585309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant melanoma of ciliary body: a case report.
    Jain SS; Thomas S; Motware SA; Hamidani A
    Indian J Ophthalmol; 1999 Dec; 47(4):255-6. PubMed ID: 10892487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital uveal malignant melanoma.
    Pukrushpan P; Tulvatana W; Pittayapongpat R
    J AAPOS; 2014 Apr; 18(2):199-201. PubMed ID: 24698625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delays in the diagnosis of uveal melanoma and effect on treatment.
    Ah-Fat FG; Damato BE
    Eye (Lond); 1998; 12 ( Pt 5)():781-2. PubMed ID: 10070508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uveal melanoma in the first 4 decades of life.
    Sagus M; Bedikian AY
    South Med J; 2015 Mar; 108(3):158-63. PubMed ID: 25772049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrepancy between fluorescence in situ hybridization and multiplex ligation-dependent probe amplification in orbital recurrence of uveal melanoma 26 years after enucleation.
    Russo A; Rene C; Coupland SE; Sagili S; Damato B
    Ophthalmic Plast Reconstr Surg; 2012; 28(6):e140-2. PubMed ID: 22460679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular metastasis from ocular melanoma: a new, rare, and unusual pathway?
    Demondion P; Garot J; Bouvier E; Balaton A; Darmon PL; Mauduit M; Fourchy D; Seknadji P; Cormier B; Donzeau-Gouge P
    Ann Thorac Surg; 2013 Jul; 96(1):e13-4. PubMed ID: 23816109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
    Kaiserman N; Kaiserman I; Hendler K; Frenkel S; Pe'er J
    Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evisceration and ocular tumors: What are the consequences?
    Lemaître S; Lecler A; Lévy-Gabriel C; Reyes C; Desjardins L; Gentien D; Zmuda M; Jacomet PV; Lumbroso-Le Rouic L; Dendale R; Vincent-Salomon A; Pierron G; Galatoire O; Cassoux N
    J Fr Ophtalmol; 2017 Feb; 40(2):93-101. PubMed ID: 28126270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rationale for implant insertion after enucleation of eyes with uveal melanoma].
    Stoiukhina AS
    Vestn Oftalmol; 2011; 127(1):29-32. PubMed ID: 21539101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iridociliary melanoma associated with ocular melanocytosis in a 6-year-old boy.
    Malik Rahman A; Augsburger JJ; Corrêa ZM
    J AAPOS; 2008 Jun; 12(3):312-3. PubMed ID: 18359649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.